logo
Exit polls show Japan's ruling coalition likely to lose key election

Exit polls show Japan's ruling coalition likely to lose key election

Yahoo20-07-2025
TOKYO — Exit polls show Prime Minister Shigeru Ishiba 's ruling coalition is likely to lose a majority in the smaller of Japan's two parliamentary houses in a key election Sunday, worsening the country's political instability.
Voters were deciding half of the 248 seats in the upper house, the less powerful of the two chambers in Japan's Diet.
Ishiba has set the bar low, wanting a simple majority of 125 seats, which means his LDP and Komeito Liberal Democratic Party and its Buddhist-backed junior coalition partner Komeito need to win 50 to add to the 75 seats they already have.
That is a big retreat from the 141 seats they had pre-election, but media surveys predict big setbacks for Ishiba.
Exit poll results released seconds after the ballots closed Sunday night mostly showed a major setback for Ishiba's coalition. Japan's NHK television projected a range of 32-51 seats for the prime minister's coalition, while other networks projected it would win just over 40 seats.
A poor performance in the election would not immediately trigger a change of government because the upper house lacks the power to file a no-confidence motion against a leader, but it would certainly deepen uncertainty over his fate and Japan's political stability. Ishiba would face calls from within the LDP party to step down or find another coalition partner.
Soaring prices, lagging incomes and burdensome social security payments are the top issues for frustrated, cash-strapped voters. Stricter measures targeting foreign residents and visitors have also emerged as a key issue, with a surging right-wing populist party leading the campaign.
Sunday's vote comes after Ishiba's coalition lost a majority in the October lower house election, stung by past corruption scandals, and his unpopular government has since been forced into making concessions to the opposition to get legislation through parliament. It has been unable to quickly deliver effective measures to mitigate rising prices, including Japan's traditional staple of rice, and dwindling wages.
President Donald Trump has added to the pressure, complaining about a lack of progress in trade negotiations and the lack of sales of U.S. autos and American-grown rice to Japan despite a shortfall in domestic stocks of the grain. A 25% tariff due to take effect Aug. 1 has been another blow for Ishiba.
Ishiba has resisted any compromise before the election, but the prospect for a breakthrough after the election is just as unclear because the minority government would have difficulty forming a consensus with the opposition.
Frustrated voters are rapidly turning to emerging populist parties. The eight main opposition groups, however, are too fractured to forge a common platform as a united front and gain voter support as a viable alternative.
The emerging populist party Sanseito stands out with the toughest anti-foreigner stance, with its 'Japanese First' platform that proposes a new agency to handle policies related to foreigners. The party's populist platform also includes anti-vaccine, anti-globalism and favors traditional gender roles.Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

​North Korea Rejects New South Korean Leader's Peace Overtures
​North Korea Rejects New South Korean Leader's Peace Overtures

New York Times

time2 minutes ago

  • New York Times

​North Korea Rejects New South Korean Leader's Peace Overtures

North Korea on Monday rejected the new South Korean president's proposal for talks, saying that his policy toward the North was no different ​than that of his ousted predecessor, under ​whom relations had plunged to the lowest point in years. Since taking office on June 4, President Lee Jae Myung of South Korea has repeatedly ​said that he wanted to ease tensions on the divided Korean Peninsula by improving ties that deteriorated under his conservative predecessor, Yoon Suk Yeol. As gestures of good will, Mr. Lee ​banned anti-North Korean activists from sending leaflets into the North by balloon. He also stopped the loudspeaker propaganda broadcasts along the border that had long angered Pyongyang.​ Earlier this month, South Korea even switched off shortwave radio broadcasts that had carried similar propaganda for over a half century. But such efforts by Mr. Lee were 'not the work worthy of appreciation,' said Kim Yo-jong, who speaks for her brother​, Kim Jong-un, ​the top leader of North Korea, in a statement carried in North Korean state media on Monday. 'No matter what policy is adopted and whatever proposal is made in Seoul, we have no interest in it and there is neither the reason to meet nor the issue to be discussed with the ROK,' Ms. Kim said, using the acronym for the South's official name, Republic of Korea. She cited the South Korean government's ongoing alliance with the United States and the countries' plans to continue holding annual joint military drills as evidence of little change under the new administration. Want all of The Times? Subscribe.

Chinese OpenAI Challenger Zhipu to Unveil New Open-Source Model
Chinese OpenAI Challenger Zhipu to Unveil New Open-Source Model

Bloomberg

time2 minutes ago

  • Bloomberg

Chinese OpenAI Challenger Zhipu to Unveil New Open-Source Model

Zhipu is releasing its biggest open-source model to date, joining a growing number of Chinese firms ramping up their free artificial intelligence offerings. The startup will release GLM-4.5, an update to its flagship model, as soon as Monday, according to a person familiar with the plan. It's trying to take on OpenAI globally as it looks to stake out a spot in a burgeoning industry and set standards for future advancements.

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics

Associated Press

time11 minutes ago

  • Associated Press

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics

Olympus Co-founds Swan EndoSurgical With Revival Healthcare Capital TOKYO - July 28, 2025 ( NEWMEDIAWIRE ) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer, and more fulfilling, today announced the conclusion of an agreement with Revival Healthcare Capital (Revival) to drive advancements in endoluminal robotics. Olympus and Revival will co-found Swan EndoSurgical, a new company dedicated to developing a novel robotic system designed to revolutionize gastrointestinal (GI) patient care in the future. Endoluminal robotics aims to empower more physicians to safely perform innovative techniques, enhancing patient access to treatment options that support safety and improved recovery times. This groundbreaking advancement has the potential to create new and significantly enhanced minimally invasive treatment options for major unmet medical needs by boosting precision and efficiency in procedures addressing ergonomic strain for healthcare professionals. Bob White, Representative Executive Officer, President and Chief Executive Officer at Olympus, commented, 'This partnership marks a significant milestone in our strategic initiative to advance endoluminal robotics. We are excited to enter this collaboration that we expect to play a pivotal role in reshaping the GI market by expanding procedural capabilities for physicians. This will allow the delivery of transformative, organ-sparing care that enhances outcomes for a broad patient population.' For decades, endoscopy - placing a flexible camera into an existing body orifice - has yielded early and accurate diagnoses of conditions such as GI tract cancer. In recent years, specialists, primarily gastroenterologists, have begun performing endoscopic therapeutic procedures, such as cancer resection, by inserting instruments through the endoscope. However, manual endoscopes and their instruments have limitations that make many advanced procedures within the lumen of the GI tract challenging and not widely available globally. The development of an endoluminal robot, with its ability to easily maneuver within the GI tract and deploy flexible arms, provides the opportunity for more patients to benefit from safe and effective procedures, potentially avoiding invasive surgery. This innovation allows for the early, safe, and effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. Furthermore, the technology has the potential for application in numerous other disease areas. Headquartered in the United States, Swan EndoSurgical has assembled a leadership team of highly experienced industry professionals who will drive technical, clinical, and commercial development of the robotic platform. About Swan EndoSurgical Swan EndoSurgical, Inc. is an innovative start-up co-founded by Revival Healthcare Capital and Olympus that is focused on the development of endoluminal surgical robotics with the aim to create effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. For additional information, visit the Company's website at or contact [email protected]. About Revival Healthcare Capital Revival Healthcare Capital is an investment firm focused on the MedTech sector. Revival specializes in transformative external innovation partnerships and other opportunities where its team of experienced operators and investors believes it can provide leadership, resources, and deep sector insights - beyond its capital - to further support companies' growth strategies. For additional information, visit Revival's website at or contact [email protected] . About Olympus At Olympus, we are committed to Our Purpose of making people's lives healthier, safer, and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis, and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit and follow our global X account: @Olympus_Corp. Media contact: Mail: [email protected] Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store